Roopal Thakkar - 27 Feb 2026 Form 4 Insider Report for AbbVie Inc. (ABBV)

Role
EVP, R&D and CSO
Signature
/s/ T.O. Odutayo, Attorney-in-Fact for Roopal Thakkar
Issuer symbol
ABBV
Transactions as of
27 Feb 2026
Net transactions value
-$1,865,227
Form type
4
Filing time
03 Mar 2026, 18:14:39 UTC
Previous filing
20 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Thakkar Roopal EVP, R&D and CSO 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO /s/ T.O. Odutayo, Attorney-in-Fact for Roopal Thakkar 03 Mar 2026 0002004979

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABBV Common Stock, $0.01 par value Tax liability $1,865,227 -8,037 -13% $232.08 52,376 27 Feb 2026 Direct
holding ABBV Common Stock, $0.01 par value 2,998 27 Feb 2026 Profit sharing trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Balance in AbbVie Savings program as of February 20, 2026. Balance includes shares acquired pursuant to a dividend reinvestment feature. This was inadvertently omitted from the Form 3 filed on December 22, 2023.